31614447|t|Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis.
31614447|a|Ceramide and sphingosine display a unique profile during brain development, indicating their critical role in myelinogenesis. Employing advanced technology such as gas chromatography-mass spectrometry, high performance liquid chromatography, and immunocytochemistry, along with cell culture and molecular biology, we have found an accumulation of sphingosine in brain tissues of patients with multiple sclerosis (MS) and in the spinal cord of rats induced with experimental autoimmune encephalomyelitis. The elevated sphingosine leads to oligodendrocyte death and fosters demyelination. Ceramide elevation by serine palmitoyltransferse (SPT) activation was the primary source of the sphingosine elevation as myriocin, an inhibitor of SPT, prevented sphingosine elevation and protected oligodendrocytes. Supporting this view, fingolimod, a drug used for MS therapy, reduced ceramide generation, thus offering partial protection to oligodendrocytes. Sphingolipid synthesis and degradation in normal development is regulated by a series of microRNAs (miRNAs), and hence, accumulation of sphingosine in MS may be prevented by employing miRNA technology. This review will discuss the current knowledge of ceramide and sphingosine metabolism (synthesis and breakdown), and how their biosynthesis can be regulated by miRNA, which can be used as a therapeutic approach for MS.
31614447	0	8	Ceramide	Chemical	MESH:D002518
31614447	13	24	Sphingosine	Chemical	MESH:D013110
31614447	39	53	Myelinogenesis	Disease	
31614447	111	129	Multiple Sclerosis	Disease	MESH:D009103
31614447	131	139	Ceramide	Chemical	MESH:D002518
31614447	144	155	sphingosine	Chemical	MESH:D013110
31614447	241	255	myelinogenesis	Disease	
31614447	478	489	sphingosine	Chemical	MESH:D013110
31614447	510	518	patients	Species	9606
31614447	524	542	multiple sclerosis	Disease	MESH:D009103
31614447	544	546	MS	Disease	MESH:D009103
31614447	574	578	rats	Species	10116
31614447	592	633	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
31614447	648	659	sphingosine	Chemical	MESH:D013110
31614447	685	690	death	Disease	MESH:D003643
31614447	703	716	demyelination	Disease	MESH:D003711
31614447	718	726	Ceramide	Chemical	MESH:D002518
31614447	740	766	serine palmitoyltransferse	Gene	189
31614447	768	771	SPT	Gene	189
31614447	814	825	sphingosine	Chemical	MESH:D013110
31614447	839	847	myriocin	Chemical	MESH:C001996
31614447	865	868	SPT	Gene	189
31614447	880	891	sphingosine	Chemical	MESH:D013110
31614447	956	966	fingolimod	Chemical	MESH:D000068876
31614447	984	986	MS	Disease	MESH:D009103
31614447	1004	1012	ceramide	Chemical	MESH:D002518
31614447	1079	1091	Sphingolipid	Chemical	MESH:D013107
31614447	1215	1226	sphingosine	Chemical	MESH:D013110
31614447	1230	1232	MS	Disease	MESH:D009103
31614447	1331	1339	ceramide	Chemical	MESH:D002518
31614447	1344	1355	sphingosine	Chemical	MESH:D013110
31614447	1496	1498	MS	Disease	MESH:D009103
31614447	Negative_Correlation	MESH:C001996	189
31614447	Negative_Correlation	MESH:D000068876	MESH:D009103
31614447	Positive_Correlation	MESH:D013110	MESH:D003711
31614447	Positive_Correlation	MESH:D002518	189
31614447	Positive_Correlation	MESH:D013110	MESH:D003643
31614447	Negative_Correlation	MESH:C001996	MESH:D013110
31614447	Positive_Correlation	MESH:D013110	189
31614447	Positive_Correlation	MESH:D013110	MESH:D004681
31614447	Negative_Correlation	MESH:D000068876	MESH:D002518
31614447	Positive_Correlation	MESH:D013110	MESH:D009103
31614447	Comparison	MESH:D002518	MESH:D013110

